The Magazine for Sleep Professionals
Saturday, July 25, 2026
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation (ODD) from the U.S. Food & Drug Administration (FDA) for the treatment of Idiopathic Hypersomnia (IH). Specifically, ODD was granted based on the plausible hypothesis that LUMRYZ may […]
Home sleep tests (HSTs) have emerged as a convenient and cost-effective alternative to traditional in-lab polysomnography (PSG) for diagnosing sleep disorders, particularly obstructive sleep apnea (OSA). Over the years, HST technology has advanced significantly, leading to improvements in accuracy and reliability. In this article, I will explore the accuracy of […]
Today, the Board of Registered Polysomnographic Technologists (BRPT) announced the winner of its A-STEP/STAR Educational Grant Program for individuals interested in pursuing a career in sleep technology and/or those who are currently working as sleep technicians who would like to become a registered polysomnographic technologist (RPSGT). Beatrice Blanch, a sleep […]
Depression is more common in people with narcolepsy.1 According to research, around 20 percent of people diagnosed with narcolepsy also experience depression, with some estimates suggesting the prevalence could be as high as 57 percent.1,2 It’s unknown if depression is a primary feature of narcolepsy, or if life is just […]
Nightmares are not just a fleeting inconvenience—they can have profound implications on mental health and overall well-being. Recent studies have suggested that nightmares are underdiagnosed and undertreated, even in sleep centers.1,2 Because it is unlikely that patients will report nightmares without provocation, it is important for providers to inquire about […]
The thought of histamines might conjure up images of itchy hives or the tickling sensation just before a sneeze, but scientists have come to realize there is much more to histamines than their connection to allergies. Recent research reveals that histamines play a vital role in wakefulness. Produced by brain […]
A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes in the standard treatment of RLS in adults. Available online as an accepted paper in the […]
A 2024 survey from the American Academy of Sleep Medicine reveals that 51% of Americans have never discussed their sleep with a health professional. The AASM advises that talking about sleep concerns can help doctors identify underlying problems and potentially diagnose a sleep disorder. “Over half (54%) of Americans believe that they don’t […]
Avadel Pharmaceuticals plc announced today that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for LUMRYZ for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy. “This approval represents an important milestone for the narcolepsy community, […]
Getting a good night’s sleep is a constant imperative across all genders, ages, and walks of life. But perhaps it is even more critical for someone “sleeping for two.”1 The literature supports that, during pregnancy, the need for sleep is increased. Further, a lack of sleep can result in negative […]
